Intellectual Property Magazine
FDA biological drug database a ‘boon’ for patients
Catherine White
US biosimilar associations have ‘applauded’ the FederalDrug Administration (FDA) for updating its ‘Purple Book’ database.
US biosimilar associations have ‘applauded’ the FederalDrug Administration (FDA) for updating its ‘Purple Book’ database.